CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- Open-market buys, last 90 days
- $38,094
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-23 | Flynn James E 10% owner | Purchase | +8,880 | $14.33 | $127K | 1,319,181 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +11,120 | $14.33 | $159K | 1,640,301 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +11,100 | $14.30 | $159K | 1,330,281 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +13,900 | $14.30 | $199K | 1,654,201 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +16,434 | $14.48 | $238K | 1,346,715 |
| 2014-12-23 | Flynn James E 10% owner | Purchase | +20,580 | $14.48 | $298K | 1,674,781 |
| 2014-12-04 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2014-12-04 | Polymeropoulos Mihael Hristos President and CEO | Grant or award · Restricted Stock Units | +50,000 | 50,000 | ||
| 2014-12-04 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-12-04 | Kelly James Patrick SVP, CFO, Sec & Treasurer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2014-12-04 | Baroldi Paolo SVP & Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2014-12-04 | Baroldi Paolo SVP & Chief Medical Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2014-05-22 | PIEN HOWARD H Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-22 | Watkins Thomas Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-22 | MILANO VINCENT Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-22 | Galson Steven K Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-22 | DUGAN RICHARD W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-05-22 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2014-03-14 | Watkins Thomas Director | Exercise or conversion | +35,000 | $9.40 | $329K | 35,000 |
| 2014-03-14 | Watkins Thomas Director | Sale | −35,000 | $17.66 | $618K | 0 |
Page 31 of 36 · 717 trades